Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Technology Industry News Why LiveRamp’s (NYSE: RAMP) Scowtt deal signals a bigger bet on first-party data performance Discover how LiveRamp Inc.’s partnership with Scowtt and its AI marketplace strategy could reshape advertising optimization and investor expectations. byVenkateshFebruary 22, 2026